Supriya Lifescience Q4 Results
- BSE: 543434
- NSE: SUPRIYA
- ISIN: INE07RO01027
- Sector: Biotechnology & Drugs
BSE
680.00
-4.90 (-0.72%)
-4.90 (-0.72%)Volume5.52 K
Updated: Fri 13 Feb, 2026 | 15:26:27
NSE
680.90-7.80 (-1.13%)
-7.80 (-1.13%)Volume1.14 L
Updated: Fri 13 Feb, 2026 | 15:29:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Supriya Lifescience Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 122.60 | 141.64 | -1.65% | 106.59 | 15.02% |
| Depreciation/ Amortization | 6.08 | 6.82 | 22.50% | 3.91 | 55.37% |
| Operating Income | 61.50 | 64.80 | 0.84% | 51.59 | 19.21% |
| Net Income | 50.38 | 49.68 | 7.69% | 36.93 | 36.41% |
| Other Operating Expenses Total | 40.72 | 48.46 | 6.76% | 27.27 | 49.32% |
| Net Income Before Taxes | 64.06 | 66.92 | 2.36% | 53.18 | 20.47% |
| Total Revenue | 184.11 | 206.44 | -0.83% | 158.18 | 16.39% |
| Selling/ General/ Admin Expenses Total | 20.98 | 24.69 | 6.09% | 17.14 | 22.36% |
| Diluted Normalized EPS | 6.29 | 6.21 | 8.01% | 4.59 | 36.95% |